Rosuvastatin Pre-Treatment Influences the Risk of Coronary Intervention Study

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.

Also called NCT01378715

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01378715
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Czechia, Slovakia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01378715. Randomized; no masking; primary purpose treatment. Start 2010-06 (registry gives no type); primary completion 2012-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Rosuvastatin Pre-Treatment Influences the Risk of Coronary Intervention Study
Acronym
TIPS-3
Intervention (Drug)
Rosuvastatin
Lead sponsor
University Hospital, Motol (class: other)

Record details

Record id
cardio:ct-nct01378715
Content hash
5ae61e5ecd2018ac12dfa8f3740696c6c7fcea51f1702971826d21a53f8f3671